Computational mining of B cell receptor repertoires reveals antigen-specific and convergent responses to Ebola vaccination

Outbreaks of Ebolaviruses, such as Sudanvirus (SUDV) in Uganda in 2022, demonstrate that species other than the Zaire ebolavirus (EBOV), which is currently the sole virus represented in current licensed vaccines, remain a major threat to global health. There is a pressing need to develop effective p...

Full description

Bibliographic Details
Main Authors: Richardson, E, Bibi, S, McLean, F, Schimanski, L, Rijal, P, Ghraichy, M, von Niederhäusern, V, Trück, J, Clutterbuck, EA, O’Connor, D, Luhn, K, Townsend, A, Peters, B, Pollard, AJ, Deane, CM, Kelly, DF
Format: Journal article
Language:English
Published: Frontiers Media 2024
_version_ 1811140277888352256
author Richardson, E
Bibi, S
McLean, F
Schimanski, L
Rijal, P
Ghraichy, M
von Niederhäusern, V
Trück, J
Clutterbuck, EA
O’Connor, D
Luhn, K
Townsend, A
Peters, B
Pollard, AJ
Deane, CM
Kelly, DF
author_facet Richardson, E
Bibi, S
McLean, F
Schimanski, L
Rijal, P
Ghraichy, M
von Niederhäusern, V
Trück, J
Clutterbuck, EA
O’Connor, D
Luhn, K
Townsend, A
Peters, B
Pollard, AJ
Deane, CM
Kelly, DF
author_sort Richardson, E
collection OXFORD
description Outbreaks of Ebolaviruses, such as Sudanvirus (SUDV) in Uganda in 2022, demonstrate that species other than the Zaire ebolavirus (EBOV), which is currently the sole virus represented in current licensed vaccines, remain a major threat to global health. There is a pressing need to develop effective pan-species vaccines and novel monoclonal antibody-based therapeutics for Ebolavirus disease. In response to recent outbreaks, the two dose, heterologous Ad26.ZEBOV/MVA-BN-Filo vaccine regimen was developed and was tested in a large phase II clinical trial (EBL2001) as part of the EBOVAC2 consortium. Here, we perform bulk sequencing of the variable heavy chain (VH) of B cell receptors (BCR) in forty participants from the EBL2001 trial in order to characterize the BCR repertoire in response to vaccination with Ad26.ZEBOV/MVA-BN-Filo. We develop a comprehensive database, EBOV-AbDab, of publicly available Ebolavirus-specific antibody sequences. We then use our database to predict the antigen-specific component of the vaccinee repertoires. Our results show striking convergence in VH germline gene usage across participants following the MVA-BN-Filo dose, and provide further evidence of the role of IGHV3–15 and IGHV3–13 antibodies in the B cell response to Ebolavirus glycoprotein. Furthermore, we found that previously described Ebola-specific mAb sequences present in EBOV-AbDab were sufficient to describe at least one of the ten most expanded BCR clonotypes in more than two thirds of our cohort of vaccinees following the boost, providing proof of principle for the utility of computational mining of immune repertoires.
first_indexed 2024-09-25T04:19:26Z
format Journal article
id oxford-uuid:c2e04aa2-ab5b-40c1-9562-f4f82cc59d01
institution University of Oxford
language English
last_indexed 2024-09-25T04:19:26Z
publishDate 2024
publisher Frontiers Media
record_format dspace
spelling oxford-uuid:c2e04aa2-ab5b-40c1-9562-f4f82cc59d012024-07-31T19:33:48ZComputational mining of B cell receptor repertoires reveals antigen-specific and convergent responses to Ebola vaccinationJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:c2e04aa2-ab5b-40c1-9562-f4f82cc59d01EnglishJisc Publications RouterFrontiers Media2024Richardson, EBibi, SMcLean, FSchimanski, LRijal, PGhraichy, Mvon Niederhäusern, VTrück, JClutterbuck, EAO’Connor, DLuhn, KTownsend, APeters, BPollard, AJDeane, CMKelly, DFOutbreaks of Ebolaviruses, such as Sudanvirus (SUDV) in Uganda in 2022, demonstrate that species other than the Zaire ebolavirus (EBOV), which is currently the sole virus represented in current licensed vaccines, remain a major threat to global health. There is a pressing need to develop effective pan-species vaccines and novel monoclonal antibody-based therapeutics for Ebolavirus disease. In response to recent outbreaks, the two dose, heterologous Ad26.ZEBOV/MVA-BN-Filo vaccine regimen was developed and was tested in a large phase II clinical trial (EBL2001) as part of the EBOVAC2 consortium. Here, we perform bulk sequencing of the variable heavy chain (VH) of B cell receptors (BCR) in forty participants from the EBL2001 trial in order to characterize the BCR repertoire in response to vaccination with Ad26.ZEBOV/MVA-BN-Filo. We develop a comprehensive database, EBOV-AbDab, of publicly available Ebolavirus-specific antibody sequences. We then use our database to predict the antigen-specific component of the vaccinee repertoires. Our results show striking convergence in VH germline gene usage across participants following the MVA-BN-Filo dose, and provide further evidence of the role of IGHV3–15 and IGHV3–13 antibodies in the B cell response to Ebolavirus glycoprotein. Furthermore, we found that previously described Ebola-specific mAb sequences present in EBOV-AbDab were sufficient to describe at least one of the ten most expanded BCR clonotypes in more than two thirds of our cohort of vaccinees following the boost, providing proof of principle for the utility of computational mining of immune repertoires.
spellingShingle Richardson, E
Bibi, S
McLean, F
Schimanski, L
Rijal, P
Ghraichy, M
von Niederhäusern, V
Trück, J
Clutterbuck, EA
O’Connor, D
Luhn, K
Townsend, A
Peters, B
Pollard, AJ
Deane, CM
Kelly, DF
Computational mining of B cell receptor repertoires reveals antigen-specific and convergent responses to Ebola vaccination
title Computational mining of B cell receptor repertoires reveals antigen-specific and convergent responses to Ebola vaccination
title_full Computational mining of B cell receptor repertoires reveals antigen-specific and convergent responses to Ebola vaccination
title_fullStr Computational mining of B cell receptor repertoires reveals antigen-specific and convergent responses to Ebola vaccination
title_full_unstemmed Computational mining of B cell receptor repertoires reveals antigen-specific and convergent responses to Ebola vaccination
title_short Computational mining of B cell receptor repertoires reveals antigen-specific and convergent responses to Ebola vaccination
title_sort computational mining of b cell receptor repertoires reveals antigen specific and convergent responses to ebola vaccination
work_keys_str_mv AT richardsone computationalminingofbcellreceptorrepertoiresrevealsantigenspecificandconvergentresponsestoebolavaccination
AT bibis computationalminingofbcellreceptorrepertoiresrevealsantigenspecificandconvergentresponsestoebolavaccination
AT mcleanf computationalminingofbcellreceptorrepertoiresrevealsantigenspecificandconvergentresponsestoebolavaccination
AT schimanskil computationalminingofbcellreceptorrepertoiresrevealsantigenspecificandconvergentresponsestoebolavaccination
AT rijalp computationalminingofbcellreceptorrepertoiresrevealsantigenspecificandconvergentresponsestoebolavaccination
AT ghraichym computationalminingofbcellreceptorrepertoiresrevealsantigenspecificandconvergentresponsestoebolavaccination
AT vonniederhausernv computationalminingofbcellreceptorrepertoiresrevealsantigenspecificandconvergentresponsestoebolavaccination
AT truckj computationalminingofbcellreceptorrepertoiresrevealsantigenspecificandconvergentresponsestoebolavaccination
AT clutterbuckea computationalminingofbcellreceptorrepertoiresrevealsantigenspecificandconvergentresponsestoebolavaccination
AT oconnord computationalminingofbcellreceptorrepertoiresrevealsantigenspecificandconvergentresponsestoebolavaccination
AT luhnk computationalminingofbcellreceptorrepertoiresrevealsantigenspecificandconvergentresponsestoebolavaccination
AT townsenda computationalminingofbcellreceptorrepertoiresrevealsantigenspecificandconvergentresponsestoebolavaccination
AT petersb computationalminingofbcellreceptorrepertoiresrevealsantigenspecificandconvergentresponsestoebolavaccination
AT pollardaj computationalminingofbcellreceptorrepertoiresrevealsantigenspecificandconvergentresponsestoebolavaccination
AT deanecm computationalminingofbcellreceptorrepertoiresrevealsantigenspecificandconvergentresponsestoebolavaccination
AT kellydf computationalminingofbcellreceptorrepertoiresrevealsantigenspecificandconvergentresponsestoebolavaccination